1. Home
  2. CNTA vs INSW Comparison

CNTA vs INSW Comparison

Compare CNTA & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTA
  • INSW
  • Stock Information
  • Founded
  • CNTA 2020
  • INSW 1999
  • Country
  • CNTA United Kingdom
  • INSW United States
  • Employees
  • CNTA N/A
  • INSW N/A
  • Industry
  • CNTA Biotechnology: Pharmaceutical Preparations
  • INSW Semiconductors
  • Sector
  • CNTA Health Care
  • INSW Technology
  • Exchange
  • CNTA Nasdaq
  • INSW Nasdaq
  • Market Cap
  • CNTA 2.3B
  • INSW 2.1B
  • IPO Year
  • CNTA 2021
  • INSW N/A
  • Fundamental
  • Price
  • CNTA $17.16
  • INSW $32.54
  • Analyst Decision
  • CNTA Strong Buy
  • INSW Strong Buy
  • Analyst Count
  • CNTA 7
  • INSW 3
  • Target Price
  • CNTA $23.71
  • INSW $60.67
  • AVG Volume (30 Days)
  • CNTA 705.7K
  • INSW 723.1K
  • Earning Date
  • CNTA 11-12-2024
  • INSW 11-07-2024
  • Dividend Yield
  • CNTA N/A
  • INSW 17.74%
  • EPS Growth
  • CNTA N/A
  • INSW N/A
  • EPS
  • CNTA N/A
  • INSW 10.33
  • Revenue
  • CNTA $6,853,000.00
  • INSW $1,007,734,000.00
  • Revenue This Year
  • CNTA N/A
  • INSW N/A
  • Revenue Next Year
  • CNTA N/A
  • INSW $1.61
  • P/E Ratio
  • CNTA N/A
  • INSW $3.15
  • Revenue Growth
  • CNTA N/A
  • INSW N/A
  • 52 Week Low
  • CNTA $6.65
  • INSW $32.11
  • 52 Week High
  • CNTA $18.97
  • INSW $65.94
  • Technical
  • Relative Strength Index (RSI)
  • CNTA 50.89
  • INSW 18.30
  • Support Level
  • CNTA $16.02
  • INSW $32.73
  • Resistance Level
  • CNTA $18.12
  • INSW $34.22
  • Average True Range (ATR)
  • CNTA 1.08
  • INSW 1.11
  • MACD
  • CNTA -0.08
  • INSW -0.26
  • Stochastic Oscillator
  • CNTA 41.42
  • INSW 5.51

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.

About INSW International Seaways Inc.

International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.

Share on Social Networks: